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Abstract. Hyperphosphatemia is known as one of the more challenging conditions 
in end-stage renal disease patients. This study set out to present and evaluate a 
healthcare-oriented decision support tool in the management of 
hyperphosphatemia within hemodialysis therapy. A prototype module was 
designed to fit into the interface of a modern dialysis machine (Fresenius 5008). 
The prototype included three main functions: 1) immediate bedside blood sample 
access, 2) a model based prognosis tool with estimates of P-phosphate and 3) an 
overview of the user´s phosphate related activities during dialysis treatments. The 
prototype was evaluated by a) heuristic evaluation with five human computer 
interaction experts and b) user testing with think-aloud by three users as (clinical) 
domain experts. The two evaluation procedures identified a total of 103 usability 
problems and led to some specific amendments to improve its practical potential. 
The overall results will guide further development of the decision support tool to 
ensure that the functions will support the user’s needs. In conclusion, the prototype 
was evaluated to be relevant and potentially beneficial in the management of 
hyperphosphatemia in hemodialysis patients. Furthermore, it was found that some 
of the functions could be used for educational purposes or as decision support for 
some patient groups, e.g. for patient doing home-dialysis.  
Keywords. Chronic kidney insufficiency, decision support systems, compartment 
modelling, phosphate, hemodialysis. 
Introduction 
Hyperphosphatemia represents one of the most challenging and frequently observed 
electrolyte disturbances in end-stage renal disease patients [1]. The condition is 
associated with severe complications such as secondary or tertiary hyperparathyroidism, 
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renal osteodystrophy and vascular calcification [1]. Prevention and treatment of the 
condition include dietary restrictions, oral phosphate binders and dialysis [2]. However, 
the management of hyperphosphatemia seems challenging due to a number of factors 
e.g. compliance problems related to diet restrictions and inadequate phosphate binder 
intake. One study indicates non-adherence in 80% of patients according to diet 
recommendations [3]. Other studies show that the prescription of a standard phosphate 
binder regimen only covers about 30 % of the meals [4]. An alternative approach 
includes extended dialysis regimes [5]. However, there is currently no standardised 
guidelines of, how long the dialysis should continue in order to achieve an optimal 
phosphate balance. Therefore, hemodialysis (HD) patients often follow a standard 
treatment program of HD four hours three times weekly.   
The removal of phosphate during a dialysis are depending on patient individual 
factors and the P-phosphate level before dialysis [6]. Hence, the regulation of dialysis 
treatment to achieve an optimal phosphate balance would require some suggestions 
about the phosphate kinetics of the individual patient. An approach to increased 
understanding of individual intra- and interdialytic phosphate behaviour could be the 
use of physiological models. Different kinetic models [7-8] have been proposed but 
only cautious suggestions have been made about the practical use of these models [7-9].  
The objective of this study was, using a model based approach, to develop and 
present a decision support tool to help healthcare professionals in the prescriptions of 
HD therapy in order to achieve an optimal phosphate removal in the individual patient 
case during a specific dialysis.  
1. Methods 
1.1. Concept and design  
A prototype was developed to support healthcare professionals in the management of 
hyperphosphatemia in HD patients. The prototype consisted of a module for the 
software of modern dialysis machines. Table 1 presents the three main functions of the 
module. The interface of the machine Fresenius 5008 was used as a proof-of-concept to 
present the prototype.  
Table 1. The three main functions of the phosphate module. 
“PO4 samples” “PO4 prognoses” “PO4 activities” 
Provides immediate 
bedside access to P-
phosphate sampling 
results. → the user to 
compare sampling results 
of different treatments 
including the ongoing HD.  
Provides decision support for the 
healthcare professional: a P-
phosphate prognosis tool with 
predictions about intra- and 
interdialytic P-phosphate levels 
based on model simulation. This 
function presupposes point-of-care 
or machine blood sampling.  
Provides an overview of the 
user’s activities related to 
phosphate during the ongoing 
or previous dialysis treatments. 
This includes time for blood 
samples, use of the prognosis 
tool and changes in HD time. 
1.2. Heuristic evaluation and think-aloud 
The prototype was evaluated by heuristic evaluation (HE) and user testing with think-
aloud (TA) to identify usability problems and to improve user experience. Alternating 
HE and TA produces the best result, as the methods identify different flaws [10]. 
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HE aims to identify and correct user interface design flaws. It involves experts 
evaluating a prototype according to recognised usability principles ("heuristics"). The 
participants included five human computer interaction experts (HCIs). Three of the 
HCIs had a MSc in Biomedical Engineering and Informatics, and two had a MSc in 
Clinical Science and Technology. All HCIs had an understanding of the healthcare 
sector in general, and three had experience with usability testing. The HCIs were asked 
to evaluate the prototype individually against Nielsen’s ten heuristics [11]: 1 – System 
status, 2 – Match between system and the real world, 3 – User control and freedom, 4 - 
Consistency and standards, 5 – Error prevention, 6 - Recognition rather than recall, 7 
- Flexibility and efficiency of use, 8 – Aesthetic and minimalist design, 9 – Help users 
recognize, diagnose, and recover from errors, 10 - Help and documentation. The 
usability problems were evaluated on a severity scale from 1-4 (cosmetic problem to 
catastrophe) [11]. If a problem was found to fit different heuristics, it was evaluated 
individually for each heuristic. Results can lead to ideas for refinements of the system. 
TA was performed to evaluate the interface and functions of the refined version of 
the prototype through analysis of user interactions with the system [12]. During the test 
procedure, the participants were encouraged to think-aloud as they were performing 
specified work-related tasks. The participants were guided individually by a test leader 
through the prototype in sessions of 30-45 minutes. A test assistant observed and noted 
each session. The participants included two dialysis nurses and one nephrologist. They 
were included as work-domain professionals (WDPs) and were all familiar with the 
Fresenius 5008 software. Results can lead to ideas for refinements.  
2. Results 
2.1. Presentation of the prototype  
Figure 1 provides a screen dump of the “PO4 prognoses” tool to illustrate part of the 
user interface and content of the prototype.  
 
Figure 1. Screen dump of the “PO4 prognoses” tool. The graph shows P-phosphate samples (red dots) and 
estimates (blue dots), end of HD (dotted black line) and current HD time (dotted red line). “HD time” is 
treatment time the user chooses to see P-phosphate estimates, and “Estimate” is length of the estimate.  
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2.2. Heuristic evaluation 
The HE identified 66 usability problems after 27 duplicates were removed. The 
heuristics were rated 104 times on the severity scale. Figure 2 shows how the violations 
were distributed against the ten heuristics and the four severity grades. The severity 
grades 1-4 were used 21, 36, 30 and 17 times, respectively, and the average severity 
rating for the ten heuristics was 2.6. Heuristic 8 was assigned the highest number of 
violations with a total of 23. However, 18 of the violations were rated 1. The most 
severe usability problems included heuristics number 2, 6 and 7.  
 
 
Figure 2. Number of times the HCIs used each of the ten heuristics and the distribution of heuristic 
violations for each heuristic against the four severity grades (1-4).  
2.3. Think Aloud  
The TA identified 37 usability problems related to the design and functions of the 
prototype. Table 2 summarises the function related feedback from the WDPs. 
Table 2. Summary of the function related feedback from the think-aloud evaluation. 
 “P-phosphate samples” “Phosphate prognoses” “Phosphate 
activities” 
Possi-
bilities 
1) Bedside information about 
the efficiency of the ongoing 
HD, 2) educational tool.  
1) Indicate if the patient could benefit of 
a prolonged HD, 2) educational tool, 3) 
tool for some patients, e.g.  home-HD. 
Overview of 
the phosphate 
activities. 
Limita-
tions 
Frequent blood sampling 
would provide the most 
applicable tool.  
Requires fast blood analysis, e.g. point-
of-care or machine sampling. 
Questionable, 
if the function 
would be used. 
Sugges-
tions  
Accessibility of numerous 
Pre-HD P-phosphate levels 
→ educational tool. 
1) Requires profound information, 2) an 
app to improve self-management skills 
in patients on home-HD.  
Could include 
blood sampling 
plan.  
3. Discussion 
This study set out to develop and test a decision support tool to help healthcare 
professionals in the management of hyperphosphatemia in HD therapy.  
The evaluation results revealed 103 usability problems. More participants would 
likely have increased the significance of the results. However, according to a statistical 
formula, 3-5 experts will identify 75-80 % of usability flaws [13].  
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The overall results indicate that the decision support was functioning. This tool 
could be beneficial to both healthcare professionals and, as suggested by WDPs, HD 
patients. Access to repeated bedside P-phosphate analysis gives opportunity to 
individualise the duration of HD for the single patient at each dialysis. The patient will 
be able to see how pre-dialysis P-phosphate influences duration of the dialysis. This 
may motivate the patient to stay on the recommended diet and take the oral phosphate 
binders as prescribed. A possibility could be to develop a patient app with the tool. This 
would be a help, especially for patients doing home-HD. However, some challenges are 
present and need to be addressed. One issue includes the required point-of-care or 
machine blood sampling, as this feature is not currently available. Another issue is how 
well the integrated model will fit the patient’s actual P-phosphate levels. This part 
would require further evaluation of current phosphate models [7]. A third issue is how 
the estimates can consider dietary intake during HD and residual kidney function.  
In conclusion, it was possible by use of HE and TA to develop a prototype of a 
phosphate decision support tool for healthcare professionals in the management of 
hyperphosphatemia within HD. However, it remains to be tested whether the patients 
will choose an extended treatment regimen based on model estimates. 
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